exagamglogene autotemcel
CRISPR,Vertex
['pivotal trial']
positive results from pivotal trials of exa-cel for transfusion-dependent beta thalassemia and severe sickle cell disease presented at the 2023 annual european hematology association (eha) congress #businesswire 
Stock Market News and Press Releases. #StockMarket & #Crypto